There is numerous scientific evidence and clinical studies that have demonstrated the beneficial role of the Mediterranean diet in which extra virgin olive oil (EVOO) occupies pride of place in counteracting the onset of non-communicable chronic-degenerative diseases such as diabetes mellitus, arterial hypertension, metabolic syndrome, neoplastic diseases, nervous system diseases and chronic kidney disease.
A daily consumption of extra virgin olive oil, as the main condiment, reduces cardiovascular risk, improves carbohydrate and lipid metabolism, helps control blood pressure and reduces inflammatory status and oxidative stress, with the latter being factors implicated in the aging process. .
A recent in vitro study conducted at the University of Rome Tor Vergata evaluated the antiproliferative capacity of olive leaf extracts, through the use of the 'Incucye S3 Live-Cell Analysis System' (Incucyte) instrument, which makes it possible the analysis of cellular behavior in real time.
The study confirmed the possible anti-tumor action exerted by the minor polar compounds of Evo oil also on this cell line never previously studied in the literature.
A further study, currently underway at the Tor Vergata polyclinic and conducted by the team coordinated by Annalisa Noce, associate professor of Nephrology at the University of Tor Vergata, is also evaluating the effects of combining the administration of a personalized Mediterranean diet with intake of a food for special medical purposes based on palmitoylethanolamide-rutin micro composite and hydroxytyrosol (an olive oil derivative) in a population of patients suffering from metabolic syndrome.
Reproduction reserved © Copyright ANSA